Managing IP is part of the Delinian Group, Delinian Limited, 8 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Vaccines and Vidal: what pharma in-house are watching in 2022

Rani Mehta
January 14, 2022
Share
pharma2022cover.jpg

Innovator and generics counsel weigh in on key court cases and why they have high hopes for Kathi Vidal

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login

Tags

IP StrategyUnited StatesNewsPatentsNorth AmericaNorth AmericaJurisdictionsLife sciences
rani-mehta-300px.png
Rani Mehta
US Reporter Managing IP
Contact
Rani reports on all aspects of IP in the US and the Americas, particularly trademarks and copyright. Based in New York, she covers in-house and private practice lawyers' concerns and insights into the market.
more from across site and ros bottom lb

More from across our site

Flag of Mexico over blue cloudy sky
Uncertainty lingers in Mexico as counsel await IP regulations
The country saw sweeping IP reform in 2020, but IMPI still needs to implement regulations governing the changes
Rani Mehta, January 30, 2023
rolls.jpg
Client buy-in will make or break IP diversity rules: sources
Sources welcome the aims of the new UK Patents Court Guide, but some are unsure it will help juniors level up
Rory O’Neill, January 30, 2023
BiosimilarCOVER.jpg
Second wave of biosimilar cases sharpens patent counsel focus
US biosimilar cases will likely settle and patent thickets could be a bugbear for companies, say three in-house counsel and three private practice lawyers
Rani Mehta, January 27, 2023
Viersen, Germany - May 9. 2020: Close up of mobile phone screen
Sandoz joins Accord in targeting US university
The claim, filed this week against the University of California’s governing board, follows action by Accord Healthcare in October
Max Walters, January 27, 2023
Nokia This week-comp.jpg
This week on MIP: EUIPO deputy eyes top role, Nokia and Samsung agree 5G licence
We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP
Max Walters, January 27, 2023
opposition-comp.jpg
Counsel demand bad faith to be used in trademark oppositions
EU lawyers say they should be allowed to cite bad faith at a much earlier stage in trademark disputes to avoid falling victim to squatters and ‘legal’ fakes
Max Walters, January 26, 2023
Football soccer children team. Kids substitute players sitting on a bench. Football sports tournament for young boys. Three kids watching football game on a pitch
Weekly take: IP juniors’ chance at first-team action long overdue
Amendments to the Patents Court Guide are a welcome step, but we must ensure everyone is on side
Max Walters, January 26, 2023
Australia.jpeg
Five patent trends to watch in Australia in 2023
Counsel expect ripple effects from last year’s seminal decisions on patent term extensions and patentability of computer-related inventions, and much more
Sukanya Sarkar, January 26, 2023
NovartisCOVER.jpg
PTAB reveals reasons for cancelling Novartis patent
The Patent Trial and Appeal Board found that claims in a Novartis patent were obvious over the prior art
Rani Mehta, January 25, 2023
AdobeStock_225279171 (1).jpeg
UKIPO faces copyright owner pushback over AI revolution
Rights owners say a copyright exception that would allow text and data mining for AI training would sell out the creative industries
Rory O’Neill, January 25, 2023